Manufacturer record
Cent Cure Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
5 batches manufactured by Cent Cure Pvt. Ltd (Himachal Pradesh) were declared Not of Standard Quality between September 2023 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: CCE26040A, Diclofenac Diethylamine, Mnethyl Salicylate, Linseed oil, Menthol Gel (exp Jan 2028). Drug Testing Laboratory, Madurai-19 (state lab) found it not of standard quality: content - Methyl Salicylate. Listed in the September 2026 alert.
Records by type
5 records linked to Cent Cure Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Diclofenac Diethylamine, Mnethyl Salicylate, Linseed oil, Menthol Gel | Batch CCE26040AMfg Feb 2026 · Exp Jan 2028 | content - Methyl SalicylateOther | Drug Testing Laboratory, Madurai-19State lab | Sep 2026 |
| CLOPIRAS 75 Tablets, Clopidogrel Bisulphate Tablets I.P. | Batch CCT241576Mfg Nov 2024 · Exp Oct 2026 | Sample does not meets the Specifications wrt. Assay of Clopidogrel as per IP.Assay | State Lab, Drugs Control Laboratory, TelanganaState lab | Jul 2025 |
| Lilion-MR Tablets (Aceclofenac, Paracetamol & Chlorzoxazone Tablets) | Batch CCT24984BMfg Jul 2024 · Exp Jun 2026 | Assay for Aceclofenac and ChlorzoxazoneAssay | State Lab KarnatakaState lab | Jun 2025 |
| Pantakos-40 (Pantoprazole Gastro-resistant Tablets IP) | Batch CCT231092 BMfg Sep 2023 · Exp Aug 2025 | THE SAMPLE DOES NOT COMPLY WITH IP REQUIREMENTS FOR DISSOLUTION IN BUFFER STAGE.Dissolution | State Lab MaharashtraState lab | Jun 2024 |
| RABEPRAZOLE SODIUM GASTRO-RESISTANT TABLETS IP (RABIRIV-20 TABLETS) | Batch CCT22065AMfg Aug 2022 · Exp Jul 2024 | Assay of Rabeprazole SodiumAssay | RDTL GuwahatiState lab | Sep 2023 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.